Rare diseases
Investigational molecules
Locations
Ehrenfelsstr. 46, 10318 Berlin, Germany
CED Studienzentrum Karlshorst, Dr. med., Thomas Brunk, Gastroenterologie Berlin in Berlin, Germany specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, and other specialisations. This site conducts important research.
At CED Studienzentrum Karlshorst in Berlin, clinical research focuses on digestive system diseases, especially Crohn’s disease and ulcerative colitis. The studies are designed to better understand how new treatments perform over time and how well they are tolerated by people living with these chronic inflammatory conditions.
The site is contributing to the assessment of therapies such as balinatunfib, with the goal of improving care for patients who need durable and effective options for chronic bowel disease.
Clinical trials currently enrolling participants at this site.
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
GermanyStudy of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients
GermanyComparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis
GermanyStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
GermanyA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
GermanyStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
GermanyStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
